Last updated 2026-10-28
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Lennart Perlhagen is a Swedish biomedical entrepreneur and investor. He was the founding investor in Novocure, a global oncology business, in 2000, and served on its board of directors for 15 years until 2018. He also founded Meda AB and served as a director on its board. Perlhagen has a background in the pharmaceutical industry, having served as CEO for Scandinavia and the UK for Farmitalia SpA and as Regional Director for South Europe at Astra AB.
Portfolio · 1
Q&A
- What is Lennart Perlhagen's primary investment focus?
- Lennart Perlhagen primarily invests in emerging healthcare companies, with a stated preference for the Health Tech & Life Sciences sector.
- What is Lennart Perlhagen's investment thesis?
- Lennart Perlhagen's investment thesis is to invest in new ideas that have the potential to change the world.
- In which geographies does Lennart Perlhagen prefer to invest?
- Lennart Perlhagen prefers to invest in companies located in Israel, the US, and Europe.
- What is a notable founding investment by Lennart Perlhagen?
- Lennart Perlhagen was the founding investor in Novocure, a global oncology business, in 2000.
- What is Lennart Perlhagen's role at Novocure?
- Lennart Perlhagen served on Novocure's board of directors for 15 years, from 2000 until 2018.
- What is Lennart Perlhagen's background in the pharmaceutical industry?
- Lennart Perlhagen has a background in the pharmaceutical industry, having served as CEO for Scandinavia and the UK for Farmitalia SpA and as Regional Director for South Europe at Astra AB. He also founded Meda AB and served as a director on its board.